axSpA patients | Healthy subjects | Pvalue | |
---|---|---|---|
n, (%) | 27 (56.25) | 23 (43.75) | |
Age, mean ± SD years | 32.9 (7.7) | 35.1 (5.4) | 0.31 |
Sex, % male | 59.5 | 52.4 | 0.61 |
HLA B27 positive, % | 91.7 | N/A | |
Duration of symptoms, median (p25-p75) years | 7.5 (5–10) | N/A | |
IBP, % | 88.5 | N/A | |
CRP, median (p25-p75) mg/l | 8.8 (2.4–12.9) | 0.27 (0.18–0.54)a) | < 0.0001 |
ESR, median (p25-p75) mm/h | 22.5 (15.0–31.0) | N/A | |
BASDAI (0–10 scale), median (p25-p75) | 2.1 (0.8–4.4) | N/A | |
ASDAS-CRP median (p25-p75) | 2.1 (1.6–3.1) | N/A | |
mNY x-ray criteria for AS (%) | 66.7 | N/A | |
mSASSS median (p25-p75) | 3 (0–72) | N/A |